Cargando…
Effectiveness of 190 µg Fluocinolone Acetonide and 700 µg Dexamethasone Intravitreal Implants in Diabetic Macular Edema Using the Area-Under-the-Curve Method: The CONSTANT Analysis
PURPOSE: Calculations of area-under-the-curve (AUC) provide the average letters gained across the entire treatment period, which may be a better estimate of long-term effectiveness than single time-point outcomes, particularly when it comes to sustained-release therapies. MATERIALS AND METHODS: The...
Autores principales: | Zarranz-Ventura, Javier, Mali, Joshua O |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319506/ https://www.ncbi.nlm.nih.gov/pubmed/32606585 http://dx.doi.org/10.2147/OPTH.S253370 |
Ejemplares similares
-
Comment on “Effectiveness of 190 µg Fluocinolone Acetonide versus 700 µg Dexamethasone Intravitreal Implants in Diabetic Macular Edema Using the Area-Under-the-Curve Method: The CONSTANT Analysis” [Response to Letter]
por: Zarranz-Ventura, Javier, et al.
Publicado: (2020) -
Letter to the Editor Regarding the “Effectiveness of 190 µg Fluocinolone Acetonide and 700 µg Dexamethasone Intravitreal Implants in Diabetic Macular Edema Using the Area-Under-the-Curve Method: The Constant Analysis” Article [Letter]
por: Taylor, Kasserine, et al.
Publicado: (2020) -
The USER Study: A Chart Review of Patients Receiving a 0.2 µg/day Fluocinolone Acetonide Implant for Diabetic Macular Edema
por: Eaton, Alexander, et al.
Publicado: (2018) -
Real-World Outcomes in Diabetic Macular Edema for the 0.2 µg/Day Fluocinolone Acetonide Implant: Case Series from the Midlands, UK
por: Mushtaq, Bushra, et al.
Publicado: (2021) -
Clinical impact of the 0.2 µg/day fluocinolone acetonide intravitreal
implant: outcomes from the ILUVIEN(®) clinical evidence study in
Portugal
por: Carneiro, Angela, et al.
Publicado: (2020)